Browsing by Subject "Vaccines"

Now showing items 1-11 of 11

    • Application of vaccines and dietary supplements in aquaculture: possibilities and challenges 
      Ringø, Einar; Olsen, Rolf Erik; Jensen, Ingvill; Romero Ormazábal, Jaime; Lauzon, Hélène L. (Kluwer Academic Publishers, 2014)
      © 2014, Springer International Publishing Switzerland. The development of vaccines has proven essential for the development of a successful finfish aquaculture industry by preventing the occurrence of diseases like ...
    • Chemoprophylaxis of recurrent otitis media Profilaxls antimicrobiana en otitis media recurrente 
      Cohen Ventura, Jacob (2004)
    • Haemophilus influenzae type b polysaccharidetetanus protein conjugate vaccine does not depress serologic ... 
      Avendano, Alfredo; Avendano, Alfredo; Lagos, Rosanna; Horwitz, Isidoro; Cayazzo, Marisol; Fritzell, Bernard; Meschievitz, Carlton; Levine, Myron (1993)
      The safety and immunogenicity of a vaccine against Haemophilus influenzae type b consisting of purified polyribosylribitol phosphate conjugated to tetanus toxoid (PRP-T) were evaluated in 277 Chilean infants who were ...
    • Parent reported outcomes to measure satisfaction, acceptability, and daily life impact after vaccination ... 
      O'Ryan Gallardo, Miguel; Calvo, Arlene E.; Espinoza Barrios, Mónica; Vega, Natalia; Lagomarcino, Anne; López Castillo, Humberto; Puentes, Esteban; Macina, Denis (Elsevier, 2020)
      Aim: To compare parental satisfaction and impact on daily life among parents of children receiving whole-cell pentavalent + oral polio vaccine (Arm 1) with an acellular hexavalent vaccine (Hexaxim; Arm 2). Methods: ...
    • Resultado de un modelo de gestión de vacunas especiales 
      Alvarado, Sylvina; Paya González, Ernesto; Valenzuela, María Teresa; Villena Martínez, Rodolfo (Sociedad Chilena de Pediatría, 2017)
      Introducción: Los pacientes pediátricos con recomendaciones especiales de vacunación son una población creciente. El Ministerio de Salud de Chile posee un programa de vacunación especial para estos casos, al cual nuestro ...
    • Rotarix™ (RIX4414): An oral human rotavirus vaccine 
      O'Ryan Gallardo, Miguel (2007)
      Rotavirus is the most common cause of severe gastroenteritis in children younger than 3 years of age worldwide. New rotavirus vaccine candidates were required to confer early protection against the most common rotavirus ...
    • Rotavirus vaccines for the developing world 
      O'Ryan Gallardo, Miguel; Hermosilla Díaz, Germán; Osorio Abarzúa, Carlos Gonzalo (Lippincott Williams, 2009)
      The authors discuss the most relevant information in the field of rotavirus vaccines published from October 2007 to June 2009; new information on the virus, host response and disease burden that relate to our understanding ...
    • The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines 
      López, Mercedes; Aguilera, Raquel; Pérez Núñez, Claudio; Mendoza Naranjo, Ariadna; Pereda, Cristian; Ramirez, Marcos; Ferrada, Carlos; Aguillón Gutiérrez, Juan Carlos; Salazar Onfray, Flavio (Elsevier GmbH, 2006)
      Immunotherapy has become a novel therapeutic alternative for various kinds of tumours. Recently, we have finalized the first phase I clinical study in Chile for the treatment of advanced malignant melanoma, using dendritic ...
    • Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for ... 
      O'Ryan Gallardo, Miguel; Vidal, Roberto; Del Canto, Felipe; Salazar, Juan Carlos; Montero, David (Taylor and Francis Inc., 2015)
      © 2015 Taylor & Francis Group, LLC.Efforts to develop vaccines for prevention of acute diarrhea have been going on for more than 40 y with partial success. The myriad of pathogens, more than 20, that have been identified ...
    • Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, ... 
      O'Ryan Gallardo, Miguel; Vidal, Roberto; Del Canto, Felipe; Salazar, Juan Carlos; Montero, David (Taylor and Francis Inc., 2015)
      © 2015 Taylor & Francis Group, LLC.In Part II we discuss the following bacterial pathogens: Shigella, Salmonella (non-typhoidal), diarrheogenic E. coli (enterotoxigenic and enterohemorragic) and Campylobacter jejuni. In ...
    • Vacunas SARS CoV-2, estudios en fase III 
      Ibáñez Guelfenbein, Catalina; Torres Torretti, Juan Pablo; Santolaya de Pablo, María Elena (Soc. Chilena Infectología, 2021)
      La enfermedad por coronavirus 2019, causada por el virus SARSCoV2, fue declarada pandemia en marzo de 2020 por la OMS. La proteína S, de la superficie viral ha sido identificada como antígeno óptimo para el desarrollo ...